Shijie Huang is the first author of a 2020 study testing why 5S ribosomal RNA is normally an independent molecule within the ribosome. The researchers engineered a covalent fusion of rearranged 5S RNA with 23S RNA and produced bacterial cells without free 5S RNA.^[ref]

The engineered cells remained viable under the tested standard conditions, and their fully assembled ribosomes could perform translation. However, they accumulated malformed large subunits that failed to form stable complete ribosomes. Cryo-electron microscopy revealed defects near the peptidyl transferase center in these misassembled particles.^[ref]

This separates two questions: whether an altered ribosome can function once assembled, and whether it assembles efficiently. The results support an assembly-related reason for preserving an independent 5S RNA. Viability in one laboratory condition does not establish that the fusion would be equally successful across environments or evolutionary timescales.

Andrew P. Laudano is a biochemistry researcher whose work with Russell F. Doolittle used synthetic peptides to investigate fibrin assembly. A historical university catalog records his UC San Diego doctorate in 1981 and lists him as an emeritus faculty member in 2013–2014.^[ref]

In the 1978 experiment, Gly-Pro-Arg-Pro bound fibrinogen and fragment D but not the central fragment E. The shorter Gly-Pro-Arg bound less tightly and inhibited polymerization less effectively. These comparisons linked the structure of a small peptide to its ability to disrupt a larger molecular assembly.^[ref]

An illuminating control is a fragment that does not bind: it helps localize the interacting region rather than merely showing that “some protein” captures the peptide. Comparing related sequences adds another constraint. Together the tests connect binding affinity, molecular location and the observable formation of a fibrin network.

Russell F. Doolittle was a researcher in protein structure and molecular evolution at UC San Diego. His investigations connected the chemistry of fibrinogen and fibrinopeptides with comparisons of inherited molecular differences among species.^[ref]

With Andrew P. Laudano, Russell F. Doolittle tested synthetic peptides resembling the exposed ends of fibrin chains. Gly-Pro-Arg-Pro bound fibrinogen and its distal fragment D and inhibited fibrin polymerization, helping locate a binding interaction involved in assembly.^[ref]

The experiment gives a small molecule an explanatory role: an imitation of one binding element can occupy a site without connecting two full-sized molecules. Interrupting network formation in this way tests a specific molecular contact. The same interest in protein sequences also supports a different kind of inference: comparing related molecules across species can reveal evolutionary relationships.

Tomas Riedel is a researcher in the interactions of blood proteins with surfaces. His 2011 study with collaborators investigated how adsorption changes fibrinogen cleavage during fibrin formation; the paper lists his affiliation at the Institute of Hematology and Blood Transfusion in Prague.^[ref]

The experiment compared dissolved fibrinogen with preparations adsorbed on polystyrene surfaces. After adding thrombin, the investigators collected released fibrinopeptides and measured them by high-performance liquid chromatography. Surface-bound preparations released Fibrinopeptide B without the characteristic delay seen in solution, and some released more Fibrinopeptide B than Fibrinopeptide A.^[ref]

For example, two preparations containing the same protein can behave differently if one presents the molecule at a surface. The result makes molecular presentation part of the explanation of enzyme access and cleavage. It cautions against transferring a solution-phase reaction sequence unchanged to every surface-bound preparation.

James M. Murphy is a researcher in protein signaling and the functions of pseudokinases, kinase-like protein domains with altered residues normally associated with catalysis. In a 2014 collaborative study, James M. Murphy and colleagues developed a thermal shift assay to classify 31 pseudokinase protein domains according to their binding of nucleotides and metal ions.^[ref]

The key distinction is between binding and chemical activity. A protein may bind ATP without efficiently transferring its phosphate group. The thermal shift assay measures changes in thermal stability associated with binding, while an ordinary kinase activity assay can register activity from a small contaminating protein kinase. The study found four binding classes, including pseudokinases with no detectable binding and others whose binding depended on metal ions. This showed why the label pseudokinase cannot substitute for testing an individual protein.^[ref]

E. Nogales is the first author of a 1998 study resolving the structure of the alpha–beta tubulin heterodimer, the building block of microtubules. The researchers used electron crystallography of zinc-induced tubulin sheets to obtain a density map at 3.7 angstrom resolution and fit an atomic model to it.^[ref]

The two related protein subunits had similar overall folds but occupied distinct positions in a heterodimer. The model identified a nucleotide-binding region and other structural regions relevant to interactions. It illustrates a practical strategy in structural biology: organize a difficult protein into a repeatable experimental specimen, measure its scattering or imaging signal, and test a molecular model against that evidence. The specimen here was an induced sheet, so interpreting it as the architecture of an intact cellular microtubule requires additional evidence.^[ref]

P. L. DeAngelis investigated the hyaluronan synthase of Pasteurella multocida, a bacterium that produces an external hyaluronic acid capsule. A 1996 study measured the enzyme's activity in cell-free membrane preparations using the activated sugar donors UDP-glucuronic acid and UDP-N-acetylglucosamine. These provide the two alternating residues of hyaluronic acid.^[ref]

Changing the available metal ions changed incorporation into the growing polysaccharide. The enzyme could use magnesium or manganese ions, but their effects differed from those reported for a related bacterial hyaluronan synthase. Thus the name of the product does not fully specify the best reaction conditions. Varying the substrates and ions turns the proposed two-sugar synthesis into a quantitative assay of an individual enzyme preparation.^[ref]

J. Bella is the first author of a 1994 X-ray crystallography study of a collagen-like peptide. The structure, determined at 1.9 angstrom resolution, resolved a collagen triple helix and the surrounding water network. It connected the overall three-chain organization with individual hydrogen bonds and interactions involving hydroxyproline residues.^[ref]

The peptide contained a single glycine-to-alanine substitution. Near that position, the three-chain structure untwisted locally and water-mediated connections replaced some direct interchain hydrogen bonds. This gives a concrete example of how one change in protein primary structure can alter a local structural arrangement without erasing the whole fold. The observation concerns the studied peptide crystal; proposed parallels with mutant collagen in tissues are a further biological interpretation.^[ref]

G. Kartha worked with G. N. Ramachandran on the structure of collagen. Their 1955 paper developed a model in which three polypeptide chains wind around one another, contributing to the explanation of the collagen triple helix. The proposed arrangement had to accommodate the amino acid composition, hydrogen bonding and the pattern of experimental X-ray diffraction.^[ref]

The history illustrates how a structural model is tested. A geometrically plausible arrangement can still require revision if its predicted repeat disagrees with measured X-ray diffraction. The value of the model lies in connecting molecular packing with several independent observations, while leaving its detailed geometry open to correction. A proposed protein structure and a later experimentally refined atomic structure represent different stages of that process.^[ref]

J. Choay is the first author of a 1983 study testing which defined fragments of heparin support binding to antithrombin. The team synthesized related four- and five-sugar structures, checked their chemical structures by nuclear magnetic resonance, and measured binding and enhancement of factor Xa inhibition.^[ref]

The tested five-sugar fragment formed an equimolar complex with antithrombin and enhanced its inhibitory activity; the four-sugar fragment did not show the same behavior. Comparing chemically defined fragments helped separate a particular residue arrangement from the heterogeneous mixture of chains in a heparin preparation. Structure confirmation and activity measurement answered different questions, and both were needed for the argument.^[ref]

I. Eronen is the first author of a 1985 study isolating and characterizing keratan sulfate from human brain. The researchers identified a sulfated carbohydrate fraction with repeating galactose and N-acetylglucosamine units. Its susceptibility to a keratan-sulfate-cleaving enzyme supplied a second test of the proposed chemical identity.^[ref]

The fraction also spanned a range of molecular sizes in size-exclusion chromatography. A material can therefore share a characteristic backbone while containing chains of different lengths. Combining chemical composition, size separation and a cleavage test makes the identification more informative than simply detecting a negatively charged substance in a tissue sample.^[ref]

T. D. Meek is the first author of a 1989 study characterizing HIV-1 protease produced in Escherichia coli. The purified enzyme processed a viral precursor protein into fragments consistent with the expected mature products. The investigators also compared molecular masses under denaturing and nondenaturing conditions and used protein cross-linking to probe subunit association.^[ref]

The apparent mass changed from about 11,000 to 22,000 between dissociated and associated conditions, consistent with a dimer. Cross-linking supplied a separate line of evidence for association. Pairing such structural measurements with an activity assay was important: a single chain observed under denaturing conditions need not be the functional unit of an active enzyme.^[ref]

J. G. Stavrianopoulos is the first author of a 1973 study purifying and characterizing calf-thymus Ribonuclease H. The investigators enriched the activity more than 3000-fold, then tested the preparation on defined RNA-DNA hybrids and on other RNA material. Activity required suitable metal ions, including magnesium or manganese under the reported conditions.^[ref]

The preparation cleaved the tested RNA-DNA hybrids but did not attack ribosomal RNA. A negative substrate result is informative here: the name ribonuclease alone does not specify which molecular arrangement an enzyme recognizes. Comparing paired nucleic-acid substrates with an RNA preparation lacking the DNA partner helped characterize specificity rather than merely establishing that some cleavage occurred.^[ref]

John E. Scott is an enzyme assay researcher and coauthor, with Kevin P. Williams, of guidance on validating enzyme preparations. The original byline associates both authors with the BRITE institute at North Carolina Central University when the chapter was prepared.^[ref]

Their methodological contribution separates three questions: is the intended enzyme present, what fraction of the protein material does it represent, and what fraction of the measured activity actually comes from it? Protein mass purity and enzymatic purity are different because a small contaminant can contribute disproportionately to an enzyme assay.^[ref]

Consider an invented preparation containing $99$ mass units of the intended enzyme and one of a contaminant. If that contaminant produces $100$ times as much assay signal per unit mass, the two components contribute $99$ and $100$ signal units. The intended enzyme supplies only $99/199\approx 49.7\%$ of the measured signal despite $99\%$ protein mass purity.

Kevin P. Williams is a researcher in enzyme assay methodology and coauthor, with John E. Scott, of guidance on assessing enzyme preparations. Their chapter distinguishes enzymatic purity from both protein mass purity and specific activity.^[ref]

The practical contribution is a strategy for testing where an assay signal comes from. Inhibitor-based comparisons, changes of substrate and comparison of assay formats can expose unwanted activities that a clean-looking SDS-PAGE band would miss.^[ref]

For example, suppose a control selectively suppresses the intended enzyme but a substantial signal remains. That observation motivates checking for another signal source; it does not, by itself, identify a second enzyme. Pairing that control with an independent enzyme assay or a different substrate helps distinguish biochemical contamination from a measurement artefact.

Jin Wu is the first author of a 2009 structural study of C3b bound to the first four domains of complement factor H. The paper's contribution statement credits Jin Wu with purifying Complement C3 and C3b, crystallizing the complex, collecting data and determining and analysing the protein structure.^[ref]

The study combined that structure with team experiments testing C3 convertase decay and complement factor I-dependent cleavage. These connected a binding arrangement to two distinct regulatory effects in the complement system.^[ref]

The division of measurements matters. A structure shows how partners fit together; an activity assay asks what changes when they interact. Agreement between these forms of evidence supports a mechanism more strongly than a binding image alone.

J. A. Huntington is the first author of a 2000 structural study explaining how an inhibitory serpin can trap and deform a protease. The team determined a crystal structure of the joined serpin–protease complex, connecting a large conformational change to loss of catalytic function.^[ref]

Attack on the reactive-center loop was associated with movement of the tethered region about $71\mathring{\mathrm{A}}$ across the serpin. The attached protease was distorted, including disruption of its active site.^[ref]

This gives a physical explanation for inhibition beyond simple obstruction of an active site. The protein scaffold changes shape after attack and carries the reacting partner into an unfavourable arrangement. The structural result identifies the trapped arrangement; the detailed time course of the moving complex remains a separate experimental question.

G. E. Davies coauthored a 1970 method for investigating protein quaternary structure through protein cross-linking. With G. R. Stark, G. E. Davies used dimethyl suberimidate, a reagent with two reactive ends, to join nearby protein subunits before analysing the resulting products.^[ref]

SDS-PAGE resolved products with masses equal to multiples of the individual protein subunit mass. A series of linked products could therefore reveal an assembly's subunit organization after treatment that would otherwise separate its components.^[ref]

For an invented three-subunit assembly with $20\mathrm{kDa}$ per subunit, partial linking could produce species near $20$, $40$ and $60\mathrm{kDa}$. Seeing only the middle species would not establish that the original assembly contained two subunits: the completeness and selectivity of the linking reaction matter.

G. R. Stark coauthored, with G. E. Davies, a 1970 experiment using protein cross-linking to investigate the organization of oligomeric proteins. The method connected a chemical intervention to a measurable series of protein subunit masses.^[ref]

After reaction with dimethyl suberimidate, detergent gel electrophoresis separated individual chains and covalently linked combinations. The experiments included assemblies with identical subunits and assemblies containing different kinds of subunits; the latter showed unequal chemical reactivities.^[ref]

The unequal-reactivity observation gives an important interpretive control. Failure to observe a linked pair need not mean that its members were far apart in the native protein: reactive groups may have been inaccessible or poorly reactive. Chemical proximity measurements must therefore be interpreted together with the chemistry used to record them.

M. Konrad authored a 1992 study isolating and characterizing the Saccharomyces cerevisiae gene for guanylate kinase. The enzyme transfers a terminal phosphoryl group from ATP to guanosine monophosphate, producing ADP and guanosine diphosphate in a reversible reaction.^[ref]

Disrupting the gene caused recessive lethality, supporting its necessity for vegetative growth under the tested conditions. Inducible gene expression also produced large quantities of guanylate kinase in both Saccharomyces cerevisiae and Escherichia coli.^[ref]

These interventions addressed complementary questions. Loss of function tested whether the native system could grow without the gene's contribution; increased expression made the protein available for biochemical measurements. The ability to express a protein abundantly does not by itself establish that the corresponding gene is essential.